MAMDC2-AS1 Induces Cuproptosis in Relapsed and Refractory Multiple Myeloma. [PDF]
Chen Y, Liu J, Zhu Y.
europepmc +1 more source
A Wolf in Sheep's Clothing: Pseudohypobicarbonatemia in a Patient With Multiple Myeloma. [PDF]
Alahmadi Z, Haq Z, Patel A, King JD.
europepmc +1 more source
Extramedullary Multiple Myeloma: Challenges and Opportunities. [PDF]
Ho M+7 more
europepmc +1 more source
Whole-body MRI for a patient with progressive multiple myeloma. [PDF]
Henning JE+7 more
europepmc +1 more source
Selinexor's Immunomodulatory Impact in Advancing Multiple Myeloma Treatment. [PDF]
Tasbihi K, Bruns H.
europepmc +1 more source
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium. [PDF]
Pasvolsky O+50 more
europepmc +1 more source
An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma. [PDF]
BarilĂ G+4 more
europepmc +1 more source
Central nervous system and osteodural multiple myeloma. [PDF]
Gozzetti A.
europepmc +1 more source
False-Positive Galactomannan Test Results in Multiple Myeloma. [PDF]
Nakamura S+9 more
europepmc +1 more source
Impact of proteostasis workload on sensitivity to proteasome inhibitors in multiple myeloma. [PDF]
Sedlacek J.
europepmc +1 more source